Recombinant SARS coronavirus Tor2 Spike glycoprotein (Ser14-Lys1193) [His tag] CHO (CAT#: GP05-380J)

Product Overview	Recombinant SARS coronavirus Tor2 Spike glycoprotein (YP_009825051.1) (Ser14-Lys1193) was produced in CHO cells6-His tag at the C-terminus. Measured by its binding ability in a functional ELISA with recombinant human ACE-2.
Biological Activity	Measured by its binding ability in a functional ELISA with recombinant human ACE-2.
Source	CHO cells
Species	SARS coronavirus Tor2
Fragment	Ser14-Lys1193
Tag	6-His tag at the C-terminus
Predicted N Terminal	Ser14
Predicted MW	136 kDa
Purity	>95%, determined by SDS-PAGE.
Endotoxin Level	<0.1 EU/μg, determined by LAL method.
Conjugation	Unconjugated

Target	S
Full Name	Spike glycoprotein
Gene ID	1489668
Accession Number	YP_009825051.1
Background	The spike (S) protein of SARS coronavirus Tor2 is considered as a protective Ag for vaccine design.
Alternate Names	E2